The data presented here suggests that while Vegfr2 heterozygosity strikingly leads to defects in tumor growth and tumor angiogenesis in all the three tumor models, additional loss of endothelial Fgfr1 and Fgfr2 displays no further effects on tumor growth and tumor angiogenesis. The gene discussed is KDR; the disease is neoplasm.